Drug treatments for covid-19: living systematic review and network meta-analysis
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …
Care for critically ill patients with COVID-19
S Murthy, CD Gomersall, RA Fowler - Jama, 2020 - jamanetwork.com
Initial reports suggest that COVID-19 is associated with severe disease that requires
intensive care in approximately 5% of proven infections. 1 Given how common the disease is …
intensive care in approximately 5% of proven infections. 1 Given how common the disease is …
[HTML][HTML] A minimal common outcome measure set for COVID-19 clinical research
JC Marshall, S Murthy, J Diaz, NK Adhikari… - The lancet infectious …, 2020 - thelancet.com
Clinical research is necessary for an effective response to an emerging infectious disease
outbreak. However, research efforts are often hastily organised and done using various …
outbreak. However, research efforts are often hastily organised and done using various …
[HTML][HTML] A clinical case definition of post-COVID-19 condition by a Delphi consensus
JB Soriano, S Murthy, JC Marshall, P Relan… - The Lancet infectious …, 2022 - thelancet.com
People with COVID-19 might have sustained postinfection sequelae. Known by a variety of
names, including long COVID or long-haul COVID, and listed in the ICD-10 classification as …
names, including long COVID or long-haul COVID, and listed in the ICD-10 classification as …
Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis
Importance Effective therapies for patients with coronavirus disease 2019 (COVID-19) are
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …
needed, and clinical trial data have demonstrated that low-dose dexamethasone reduced …
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
…, BJ McVerry, SK Montgomery, SC Morpeth, S Murthy… - Medrxiv, 2021 - medrxiv.org
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
…, B McVerry, S Montgomery, P Mouncey, S Murthy… - Jama, 2020 - jamanetwork.com
Importance Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19)
is limited. Objective To determine whether hydrocortisone improves outcome for …
is limited. Objective To determine whether hydrocortisone improves outcome for …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
…, B McVerry, S Montgommery, P Mouncey, S Murthy… - Jama, 2021 - jamanetwork.com
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
[HTML][HTML] Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of …
…, HB Mezgebe, FW Mlashu, S Murthy… - The Lancet Infectious …, 2018 - thelancet.com
Background The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016
provides an up-to-date analysis of the burden of diarrhoea in 195 countries. This study …
provides an up-to-date analysis of the burden of diarrhoea in 195 countries. This study …
[HTML][HTML] Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic …
…, MA Mohammed, F Momeniha, S Murthy… - The Lancet infectious …, 2018 - thelancet.com
Background Lower respiratory infections are a leading cause of morbidity and mortality around
the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, …
the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, …